We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sunitinib paves the way for targeted therapies in neuroendocrine tumors.
- Authors
Raymond, Eric; Faivre, Sandrine; Hammel, Pascal; Ruszniewski, Philippe
- Abstract
Sunitinib demonstrating efficacy in pancreatic islet cell carcinomas will pave the way for further trials in other neuroendocrine tumor types such as carcinoid, poorly differentiated neuroendocrine disease, and several other endocrine tumors that are dependent on VEGF/VEGFR for angiogenesis. In addition, other drugs with distinct mechanisms of action, such as mTOR inhibitors, currently investigated in phase III trials, may also supply novel options in those diseases to control tumor growth and metastasis.
- Publication
Targeted oncology, 2009, Vol 4, Issue 4, p253
- ISSN
1776-260X
- Publication type
Journal Article
- DOI
10.1007/s11523-009-0130-0